Radiomer Therapeutics
Radiopharmaceutical/radioligand therapy platform creating targeted radionuclide therapeutics using peptide–oligonucleotide hybrid Raptamers as targeting vectors.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
